Pascal Biosciences Inc(DE:8DZ)
€0.02+0.01 (+83.33%)
DE:8DZ
Pascal Biosciences Inc financials statements
€0.02
At close:+0.01 (+83.33%)
Pascal Biosciences Inc (8DZ) Income Statement
0 Followers
Pascal Biosciences Inc Income Statement
Last quarter (Q2 2026), Pascal Biosciences Inc's total revenue was C$399.51K, a decrease of 4.59% from the same quarter last year. In Q2, Pascal Biosciences Inc's net income was C$-38.59K. See Pascal Biosciences Inc’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Nov 25 | Feb 25 | Feb 24 | Nov 22 | Feb 22 |
|---|---|---|---|---|---|
| C$ 1.70M | C$ 1.55M | C$ 671.54K | C$ 0.00 | C$ 0.00 | |
| C$ 396.31K | C$ 1.08M | C$ 392.94K | C$ -8.29K | C$ -16.32K | |
| C$ 686.76K | C$ 1.30M | C$ 1.26M | C$ 548.59K | C$ 1.06M | |
| Depreciation and Amortization | C$ 257.79K | C$ 251.42K | C$ 106.94K | C$ 8.29K | C$ 16.32K |
| C$ -32.66K | C$ -48.07K | C$ -271.56K | C$ -468.09K | C$ -1.07M | |
| C$ -290.45K | C$ -220.15K | C$ -868.13K | C$ -556.88K | C$ -1.08M | |
| C$ 15.38K | C$ -142.33K | C$ 468.36K | C$ 25.35K | C$ -7.87K | |
| C$ -275.07K | C$ -362.48K | C$ -399.77K | C$ -480.28K | C$ -1.09M | |
| C$ -275.07K | C$ -362.48K | C$ -399.77K | C$ -480.28K | C$ -1.09M | |
| Per Share Metrics | |||||
| Basic EPS | C$ -0.01 | C$ -0.01 | C$ -0.02 | C$ -0.04 | C$ -0.09 |
| Diluted EPS | C$ -0.01 | C$ -0.01 | C$ -0.02 | C$ -0.04 | C$ -0.09 |
| Weighted Average Shares Outstanding | 39.66M | 38.33M | 23.53M | 13.11M | 12.70M |
| Weighted Average Shares Outstanding (Diluted) | 39.66M | 38.33M | 23.53M | 13.11M | 12.70M |
Currency in CAD

